An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica

Veterinary Parasitology

Volumn 162, Issue 1-2, 2009, Pages 75-88

  McConville, M ^a   Brennan, G P ^a   Flanagan, A ^a   Edgar, H W J ^b   Hanna, R E B ^b   McCoy, M ^b   Gordon, A W ^b   Castillo, R ^c   Hernandez Campos A ^c   Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Compound alpha; Efficacy; Experimental fasciolicide; Fasciola hepatica; Liver fluke; Triclabendazole resistance

Indexed keywords

COMPOUND ALPHA; FASCIOLICIDE; GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE DEHYDROGENASE; LIVER ENZYME; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BILE DUCT; CONTROLLED STUDY; CYST (RESTING STAGE); DRUG ACTIVITY; DRUG EFFICACY; ENZYME ACTIVITY; FASCIOLA HEPATICA; FASCIOLIASIS; FECES ANALYSIS; FEMALE; MALE; NONHUMAN; OVARY; PARASITE ISOLATION; PARASITEMIA; SHEEP; STAINING; TESTIS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMATODE; UTERUS;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; IMIDAZOLES; MALE; NAPHTHALENES; SHEEP; SHEEP DISEASES;

FASCIOLA HEPATICA; OVIS ARIES; VITELLARIA;

EID: 65349136977     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2009.02.004     Document Type: Article

References (59)

1. Álvarez-Sánchez M.A., Mainar-Jaime R.C., Pérez-García J., and Rojo-Vázquez F.A. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain. Vet. Rec. 159 (2006) 424-425
2. Anderson P.H., Berrett S., Brush P.J., Hebert C.N., Parfitt J.W., and Patterson D.S.P. Biochemical indicators of liver injury in calves with experimental fascioliasis. Vet. Rec. 100 (1977) 43-45
3. Anon, 1995. Resistance to fluke drug found on Sligo farm. Irish Farmers' J. 18th March, p. 2.
4. Anon. Report of the Scottish Agricultural College's Veterinary Science Division. Vet. Rec. 143 (1998) 653-654
5. Behm C.A., and Sangster N.C. Pathology, pathophysiology and clinical aspects. In: Dalton J.P. (Ed). Fasciolosis (1999), CAB International Publishing, Oxon, UK 185-224
6. Boray J.C., and Pearson I.G. The anthelmintic efficiency of tetrachlorodifluoroethane in sheep infected with Fasciola hepatica. Aust. Vet. J. 36 (1960) 331-337
7. Boray J.C., Crowfoot P.D., Strong M.B., Allison J.R., Schellenbaum M., Orelli M., and Von Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Rec. 113 (1983) 315-317
8. Borstnik K., Paik I.-H., Shapiro T.A., and Posner G.H. Antimalarial chemotherapeutic peroxides: artemisinin, yinghaosu A and related compounds. Int. J. Parasitol. 32 (2002) 1661-1667
9. Bulgin M.S., Anderson B.C., Hall R.F., and Land B.Z. Serum gamma glutamyl transpeptidase activity in cattle with induced fascioliasis. Res. Vet. Sci. 37 (1984) 167-171
10. Chauvin A., Bouvet G., and Boulard C. Humoral changes and cellular immune responses to Fasciola hepatica experimental primary and secondary infection in sheep. Int. J. Parasitol. 25 (1995) 1227-1241
11. Coles G.C., and Stafford K.A. Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. Vet. Rec. 148 (2001) 723-724
12. Coles G.C., Rhodes A.C., and Stafford K.A. Activity of closantel against adult triclabendazole-resistant Fasciola hepatica. Vet. Rec. 146 (2000) 504
13. Ferre I., López P., Gonzalo-Orden M., Julian M.D., Rojo-Vázquez F.A., and Gonzalez-Gallego J. The effects of subclinical fasciolosis on hepatic secretory function in sheep. Parasitol. Res. 81 (1995) 127-131
14. Ferre I., López P., Rojo-Vázquez F.A., and Gonzalez-Gallego J. Experimental ovine fascioliasis: antipyrine clearance as indicator of liver damage. Vet. Parasitol. 62 (1996) 93-100
15. Ferre I., Ortega L.M., and Rojo-Vázquez F.A. Serum and bile antibody responses (IgG and IgA) during subclinical Fasciola hepatica infection in sheep. Vet. Parasitol. 68 (1997) 261-267
16. Galtier P., Larrieu G., Tufenkji A.E., and Franc M. Incidence of experimental fascioliasis on the activity of drug metabolising enzymes in lamb liver. Drug Metab. Dispos. 14 (1986) pp. 173-141
17. Gaasenbeek C.P.H., Moll L., Cornelissen J.B.W.J., Vellema P., and Borgsteede F.H.M. An experimental study on triclabendazole resistance of Fasciola hepatica in sheep. Vet. Parasitol. 95 (2001) 37-43
18. Gonzalo-Orden M., Millán L., Álvarez M., Sáanchez-Campos S., Jiménez R., Gonzáalez-Gallego J., and Tuñón M.J. Diagnostic imaging in sheep hepatic fascioliasis: ultrasound, computer tomography and magnetic resonance findings. Parasitol. Res. 90 (2003) 359-364
19. Halferty L., Brennan G.P., Hanna R.E.B., Edgar H.W., Meaney M.M., McConville M., Trudgett A., Hoey L., and Fairweather I. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole. Vet. Parasitol. 155 (2008) 49-58
20. Hanna R.E.B., Cromie L., Taylor S.M., and Couper A. The effect of a parenteral ivermectin/closantel injection on the growth and reproductive development of early immature Fasciola hepatica in cattle. Vet. Parasitol. 142 (2006) 78-90
21. Hanna R.E.B., Edgar H., Moffett D., McConnell S., Fairweather I., Brennan G.P., Trudgett A., Hoey E.M., Cromie L., Taylor S.M., and Daniel R. Fasciola hepatica: histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally-infected hosts. Vet. Parasitol. 157 (2008) 222-234
22. Hennessy D.R., Lacey E., Steel J.W., and Prichard R.K. The kinetics of triclabendazole disposition in sheep. J. Vet. Pharmacol. Ther. 10 (1987) 64-72
23. Hernández-Campos A., Ibarra-Velarde F., Vera-Montenegro Y., Rivera-Fernandez N., and Castillo R. Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole. Chem. Pharm. Bull. 50 (2002) 649-652
24. Howie F. Necropsy and sampling techniques. In: Martin W.B., and Aitken I.D. (Eds). Diseases of Sheep. third edition (2000), Blackwell Science Ltd., Oxford 480-496
25. Ibarra V.F., García S.E., Fernández R.M., Vera M.Y., Castillo B.R., and Hernández C.A. Eficacia fasciolicida de dos compuestos de síntesis química in vitro e in vivo en ovinos. Vet. Méx. 8 (1997) 4-8
26. Ibarra V.F., Vera M.Y., Hernández C.A., and Castillo B.R. Eficacia fasciolicida del compuesto "alfa" contra estadios juveniles y adultos en ovinos. Vet. Méx. 28 (1997) 297-301
27. Ibarra V.F., Montenegro C.N., Flores C.J., Hernández C.A., and Castillo B.R. Evaluación de cuatro vehículos para formular un fasciolicida experimental. Vet. Méx. 31 (2000) 47-51
28. Ibarra-Velarde F., Vera-Montenegro Y., López-Arellano R., Cantó-Alarcón G., Castillo-Bocanegra R., and Hernández-Campos A. Compound alpha: comparison of two fasciolicide formulations in cattle. Int. J. Appl. Res. Vet. Med. 3 (2005) 266-270
29. Ibarra F., Vera Y., Quiroz H., Cantó J., Castillo R., Hernández A., and Ochoa P. Determination of the effective dose of an experimental fasciolicide in naturally and experimentally infected cattle. Vet. Parasitol. 120 (2004) 65-74
30. Keiser J., and Utzinger J. Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr. Opin. Infect. Dis. 20 (2007) 605-612
31. Keiser J., Shu-Hua X., Tanner M., and Utzinger J. Artesunate and artemether are effective fasciolicides in the rat model and in vitro. J. Antimicrob. Chemother. 57 (2006) 1139-1145
32. Keiser J., Utzinger J., Vennerstrom J.L., Dong Y., Brennan G.P., and Fairweather I. Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica. Trans. R. Soc. Trop. Med. Hyg. 101 (2007) 1219-1222
33. Lane G. Anthelmintic resistance. Vet. Rec. 143 (1998) 332
34. Matanović K., Severin K., Martinković F., Šimpraga M., Janicki Z., and Barišić J. Hematological and biochemical changes in organically farmed sheep naturally infected with Fasciola hepatica. Parasitol. Res. 101 (2007) pp. 1675-1661
35. McConville M., Brennan G.P., McCoy M., Castillo R., Hernandez-Campos A., Ibarra F., and Fairweather I. Adult triclabendazole resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitology 133 (2006) 195-208
36. McConville M., Brennan G.P., McCoy M., Castillo R., Hernandez-Campos A., Ibarra F., and Fairweather I. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitol. Res. 100 (2007) 365-377
37. McConville M., Brennan G.P., Flanagan A., Edgar H.W.J., McCoy M., Castillo R., Hernández-Campos A., and Fairweather I. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Vet. Parasitol. 153 (2008) 52-64
38. McConville, M., Brennan, G.P., Flanagan, A., Edgar, H.W.J., Castillo, R., Hernández-Campos, A., Fairweather, I.. Ultrastructural changes to the tegumental system and the gastrodermal cells in mature flukes following in vivo treatment with the experimental fasciolicide, compound alpha. Parasitology, in press.
39. McCoy M.A., Fairweather I., Brennan G.P., Kenny J.M., Ellison S., and Forbes A.B. The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabendazole-resistant Fasciola hepatica in sheep. Res. Vet. Sci. 78 Suppl. A (2005) 33
40. Mestorino N., Formentini E.A., Lucas M.F., Fernandez C., Modamio P., Mariño Hernández E., and Errecalde J.O. Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulphoxide. Vet. Res. Commun. 32 (2008) 21-33
41. Mitchell G.B.B., Maris L., and Bonniwell M.A. Triclabendazole-resistant liver fluke in Scottish sheep. Vet. Rec. 143 (1998) 399
42. Moll L., Gaasenbeek C.P.H., Vellema P., and Borgsteede F.H.M. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in the Netherlands. Vet. Parasitol. 91 (2000) 153-158
43. Mottier L., Alvarez L., Fairweather I., and Lanusse C. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. J. Parasitol. 92 (2006) 1355-1360
44. Overend D.J., and Bowen F.L. Resistance of Fasciola hepatica to triclabendazole. Aust. Vet. J. 72 (1995) 275-276
45. Raadsma H.W., Kingsford N.M., Suharyanta, Spithill T.W., and Piedrafita D. Host responses during experimental infection with Fasciola gigantica and Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection. Vet. Parasitol. 143 (2007) 275-286
46. Ramírez, N., Mayet, L., Del Rivero, L., Ibarra-Velarde, F., Castillo, R., Hernández-Campos, A., Jung-Cook, H., 2009. Pharmacokinetic behaviour in sheep and cattle of 5-Chloro-2-(methylthio)-6-(1-naphthyloxy)-1H-benzimidazole, a new fasciolicide agent. J. Vet. Pharmacol. Ther., in press.
47. Rivera F.N., Ibarra V.F., Olazaràn J.S., Vera M.Y., Castillo B.R., and Hernández C.A. Efficacy of 5-chloro-2-methylthio-6-(1-naftiloxi)-ih-benzimidazole against different stages of Fasciola hepatica in Pelibuey sheep. Vet. Méx. 33 (2002) 55-61
48. Robinson M.W., Trudgett A., Hoey E.M., and Fairweather I. Triclabendazole-resistant Fasciola hepatica: ß-tubulin and response to in vitro treatment with triclabendazole. Parasitology 124 (2002) 325-338
49. Robinson M.W., Lawson J., Trudgett A., Hoey E.M., and Fairweather I. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol. Res. 92 (2004) 205-210
50. Simesen M.G., Nielsen K., and Nansen P. Some effects of experimental Fasciola hepatica infection in cattle on the serum activities of theta-glutamyl transpeptidase and glutamic oxaloacetic transaminase. Res. Vet. Sci. 15 (1973) 32-36
51. Sykes A.R., Coop R.L., and Robinson M.G. Chronic subclinical ovine fascioliasis: plasma glutamate dehydrogenase, gamma-glutamyl transpeptidase and aspartate aminotransferase activities and their significance as diagnostic aids. Res. Vet. Sci. 28 (1980) 71-75
52. Thomas I., Coles G.C., and Duffus K. Triclabendazole-resistant Fasciola hepatica in southwest Wales. Vet. Rec. 146 (2000) 200
53. Torgerson P., and Claxton J. Epidemiology and control. In: Dalton J.P. (Ed). Fasciolosis (1999), CAB International Publishing, Oxon, UK 113-149
54. Vera Montenegro Y., Ibarra Velarde F., Quiroz Romero H., Hernández Campos A., and Castillo R. Field trial on the efficacy of an experimental fasciolicide compared with some commercial compounds in naturally infected cattle. Parasitol. Res. 91 (2003) 1-4
55. Vera Montenegro Y., Ibarra Velarde F., Liébano Hernàndez E., Quiroz Romero H., Castillo Bocanegra R., Hernández Campos A., and Ochoa Galván P. Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves. Parasitol. Res. 92 (2004) 211-214
56. Virkel G., Lifschitz A., Sallovitz J., Pis A., and Lanusse C. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep. J. Vet. Pharmacol. Ther. 29 (2006) 213-223
57. Walker S.M., Hoey E., Fletcher H., Brennan G., Fairweather I., and Trudgett A. Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica. Parasitology 133 (2006) 209-216
58. Zhang W., Moreau E., Peigne F., Huang W., and Chauvin A. Comparison of modulation of sheep, mouse and buffalo lymphocyte responses by Fasciola hepatica and Fasciola gigantica excretory-secretory products. Parastiol. Res. 95 (2005) 333-338
59. Zhang W.Y., Moreau E., Hope J.C., Howard C.J., Huang W.Y., and Chauvin A. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep. Exp. Parasitol. 111 (2005) 154-159